I appreciate it. I apologize for having to intervene. It's because I have such limited time.
I appreciate that comment, but ultimately it still comes down to the provinces needing to make those decisions on what they believe—as Quebec has done, and every other province should be doing—is best for them.
Mr. Adams, I appreciate what you presented and the eight recommendations you put forward. I think there are some good things about them. Ultimately, when we look at the legislation and the amendments we're dealing with in this little piece that we have right now. The scary part is whether that will grow over time. I think in some ways one of your recommendations relates to what's talked about with the national formulary, when we talk about the Canadian drug agency.
I'll just read one of your recommendations to you. It says, “The Canadian Drug Agency must be established in legislation rather than at the direction of the Minister of Health, subject to Parliamentary oversight, the Access to Information Act, Auditor General scrutiny and interventions by a Patient Ombudsman.”
Those are recommendations that are suggesting in many ways, in particular for this agency...but we've also seen this in the legislation where we talk about building a committee but we have no idea who those people will be in those roles. I'm just wondering if you could comment on that.